Literature DB >> 29860534

Molecular imaging and molecular diagnostics: two sides of the same coin?

Marcus Hacker1,2, Gregor Hoermann3,4, Lukas Kenner5,6,7,8.   

Abstract

Mesh：

Year:  2018        PMID： 29860534     DOI： 10.1007/s00259-018-4060-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  19 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

3.  Clinical development success rates for investigational drugs.

Authors:  Michael Hay; David W Thomas; John L Craighead; Celia Economides; Jesse Rosenthal
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

4.  Molecular imaging with 11C-PD153035 PET/CT predicts survival in non-small cell lung cancer treated with EGFR-TKI: a pilot study.

Authors:  Xue Meng; Billy W Loo; Li Ma; James D Murphy; Xindong Sun; Jinming Yu
Journal:  J Nucl Med       Date:  2011-09-08       Impact factor: 10.057

Review 5.  Liquid biopsies come of age: towards implementation of circulating tumour DNA.

Authors:  Jonathan C M Wan; Charles Massie; Javier Garcia-Corbacho; Florent Mouliere; James D Brenton; Carlos Caldas; Simon Pacey; Richard Baird; Nitzan Rosenfeld
Journal:  Nat Rev Cancer       Date:  2017-02-24       Impact factor: 60.716

Review 6.  Tumour heterogeneity and resistance to cancer therapies.

Authors:  Ibiayi Dagogo-Jack; Alice T Shaw
Journal:  Nat Rev Clin Oncol       Date:  2017-11-08       Impact factor: 66.675

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

8.  Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients.

Authors:  Anne Winther-Larsen; Joan Fledelius; Christina Demuth; Catharina M Bylov; Peter Meldgaard; Boe S Sorensen
Journal:  Transl Oncol       Date:  2016-10-29       Impact factor: 4.243

9.  Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers.

Authors:  Rifeng Jiang; Ximin Dong; Wenzhen Zhu; Qing Duan; Yunjing Xue; Yanxia Shen; Guopeng Zhang
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

10.  Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients.

Authors:  Anne Winther-Larsen; Christina Demuth; Joan Fledelius; Anne Tranberg Madsen; Karin Hjorthaug; Peter Meldgaard; Boe Sandahl Sorensen
Journal:  Br J Cancer       Date:  2017-07-06       Impact factor: 7.640
View more
  1 in total

Review 1.  Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer.

Authors:  Orazio Schillaci; Manuel Scimeca; Nicola Toschi; Rita Bonfiglio; Nicoletta Urbano; Elena Bonanno
Journal:  Contrast Media Mol Imaging       Date:  2019-07-01       Impact factor: 3.161
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.